EdiGene is a dedicated to the development of genome editing technology for human health. Founded by Wei Wensheng in 2015, EdiGene is backed by investors that include Green Pine Capital, Huagai Capital, IDG Capital, Lilly Asia Ventures, and WI Harper Group. EdiGene is headquartered in Beijing.
FOUNDED:
2015
INDUSTRY:
Biotechnology, Enterprise
FOUNDERS:
Wei Wensheng
You are seconds away from signing up for the hottest list in New York Tech!
Join the millions and keep up with the stories shaping entrepreneurship. Sign up today.
